Canary Foundation is a non-profit dedicated to the goal of identifying cancer early through a simple blood test and then isolating it with imaging. Our collaborative research programs span multiple disciplines and institutions.

Learn About Canary's One Million Dollar Equipment Campaign. With your help, we're making progress.

Canary Center at Stanford is taking a bold step closer to making cancer early detection a reality.

Donor pledges 500 thousand dollars for equipment if matched. Help us put tools in the hands of the greatest minds in cancer research.

Click here for details and catalogue

Canary Founder Don Listwin Appointed to Isilon Systems Board of Directors. Listwin joins the global leader in scale-out storage, intrigued by its "disruptive technology." More

At AACR, Director of the Canary Center at Stanford Describes a New Role for Ultrasound in the Cancer Clinic. Dr. Sam Gambhir justifies the use of widely accessible ultrasound in cancer early detection. More

New Development of Simple Blood Test for Cancer Early Detection. The new test, developed after 15 years of research by clinicians is to be introduced in America later this month to initially help screen smokers at high risk of lung cancer. More

New Tests for Prostate Cancer Might Bring More Certainty: Researchers believe gene-based screens could reduce unnecessary biopsies and anxieties. More

New Approach to an Old Test: Researchers have found a new way to use an existing blood test that may provide a way to screen women for ovarian cancer, earlier. More

Why Cancer Screenings May Soon Be as Easy as Taking a Pregnancy Test: O Magazine has published an article on cancer diagnostics and the future of cancer early detection, including commentary by Canary Foundation Founder Don Listwin. More

Don Listwin Talks Philanthro-Capitalism at the VEF: On Tuesday, April 27, 2010 Don Listwin addressed the Vancouver Enterprise Forum (VEF) on applying business practices to the non-profit world in order to affect change. Specifically, Don conveyed the importance of disruptive change in cancer early detection. To read the article, click here. Many thanks to all the support from TechVibes!

Sharing Databases for Disease Research: Sage Bionetworks is driving an effort to build an open-source collaborative effort where data and disease models can be shared amongst a network of scientists. More (pdf)

Prostate Research Imaging and Men’s Education (PRIME) Act Re-introduced: The PRIME Act calls for $650 million to improve imaging and blood tests for early detection and treatment of prostate cancer. This includes $500 million for research to develop new imaging technologies for improved early detection and minimally-invasive, patient-tailored treatment; $100 million to develop more specific blood and/or urinary tests for mass screening and prevention; and $50 million for men’s education. More

OVA1 Test to Help Determine if Ovarian Masses Are Cancer: The Wall Street Journal reports that the OVA1 test was shown to correctly flag 92% of cancers, when used along with radiological imaging and a standard patient work-up. Though the development marks great progress in ovarian cancer early detection, false positives continue to afflict an ultimate solution. More

Executive Editor of Wired Magazine, Thomas Goetz, proposes a new strategy for thinking about health: In his new book, The Decision Tree, Goetz assesses the impact that technology will have on personal health. An individual’s Decision Tree begins with genomics, where $400 and a test tube of spit provides a peek at how your DNA influences your health. Full of thoughtful, groundbreaking reporting on the impact personalized medicine will have on the average patient, The Decision Tree will show you how to take advantage of this new frontier in health care. Chapter 7, “Canaries in the Coal Mine,” reviews Canary Foundation’s platform for cancer early detection. More